RUA Life Sciences plc (AIM: RUA)
London
· Delayed Price · Currency is GBP · Price in GBX 13.48
+0.48 (3.69%)
Jan 22, 2025, 8:14 AM GMT+1
RUA Life Sciences Revenue
RUA Life Sciences had revenue of 1.52M GBP in the half year ending September 30, 2024, with 38.04% growth. This brings the company's revenue in the last twelve months to 2.92M, up 56.29% year-over-year. In the fiscal year ending March 31, 2024, RUA Life Sciences had annual revenue of 2.19M with 0.55% growth.
Revenue (ttm)
2.92M
Revenue Growth
+56.29%
P/S Ratio
2.38
Revenue / Employee
73.03K
Employees
40
Market Cap
8.07M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 2.19M | 12.00K | 0.55% |
| Mar 31, 2023 | 2.18M | 554.00K | 34.09% |
| Mar 31, 2022 | 1.63M | 97.00K | 6.35% |
| Mar 31, 2021 | 1.53M | 1.04M | 212.47% |
| Mar 31, 2020 | 489.00K | 26.00K | 5.62% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 38.20B |
| GSK plc | 31.31B |
| Haleon | 11.24B |
| Smith & Nephew | 4.46B |
| ConvaTec Group | 1.74B |
| Hikma Pharmaceuticals | 2.39B |
| HUTCHMED (China) | 483.31M |
| Oxford Nanopore Technologies | 167.75M |